Changes in the use of analogue insulins in 37 206 children and adolescents with type 1 diabetes in 275 German and Austrian centers during the last twelve years

Experimental and Clinical Endocrinology and Diabetes

Volumn 117, Issue 7, 2009, Pages 329-335

  Kapellen, T M ^a   Wolf, J ^b   Rosenbauer, J ^c   Stachow, R ^d   Ziegler, R ^d   Szczepanski, R ^e   Holl, R W ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Hospital for Children and Adolescents   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d Inselklinik ^*

^e UNIVERSITY OF ULM   (Germany)

Author keywords

Adolescents; Analogue insulin; Children; Long acting analogue; Short acting analogue; Type 1 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ISOPHANE INSULIN; LONG ACTING INSULIN; ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ADULT; ARTICLE; AUSTRIA; BODY MASS; CHILD; COHORT ANALYSIS; COMA; DISEASE SEVERITY; FEMALE; GERMANY; GLYCEMIC CONTROL; GROUPS BY AGE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NEWBORN; ONSET AGE; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; BLOOD; CLINICAL TRIAL; INFANT; LONGITUDINAL STUDY; METABOLISM; MULTICENTER STUDY; SELF CARE; TIME;

ADOLESCENT; AUSTRIA; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GERMANY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INFANT, NEWBORN; INSULIN; LONGITUDINAL STUDIES; MALE; SELF CARE; TIME FACTORS; YOUNG ADULT;

EID: 70349567355     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0028-1103289     Document Type: Article

References (26)

1. Danne T, Aman J, Schober E et al. A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetes. Diabetes Care 2003; 26: 2359-2364
2. Danne T, Rastam J, Odendahl R et al. Parental preference of prandial insulin aspart compared with preprandial human insulin in a basalbolus scheme with NPH insulin in a 12-wk crossover study of pre-school children with type 1 diabetes. Pediatr Diabetes. 2007; 8: 278-285
3. Deeb LC, Holcombe JH, Brunelle R et al. Insulin lispro lowers postprandial glucose in prepubertal children with diabetes. Pediatrics 2001; 108: 1175-1179
4. Deiss D, Kordonouri O, Hartmann R et al. Treatment with insulin glargine reduces asymptomatic hypoglycaemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetes. Pediatric Diabetes 2007; 8: 157-162
5. Deja G, Jarosz-Chobot P, Polanska J. The rate of improvement in metabolic control in children with diabetes mellitus type 1 on insulin glargine depends on age. Exp Clin Endocrinol Diabetes 2007; 10
6. Ford-Adams ME, Murphy NP, Moore EJ et al. Insulin lispro: a potential role in preventing nocturnal hypoglycaemia in young children with diabetes mellitus. Diabetic Medicine 2003; 20: 656-660
7. Gale EAM. The rise of childhood type 1 diabetes in the 20 th century. Diabetes 2002; 51: 3353-3361
8. Gerstl E-M, Rabl W, Rosenbauer J et al. Metabolic control as reflected by HbA1c in children, adolescents and young adults with type 1 diabetes mellitus: combined longitudinal analysis including 27035 patients from 207 centers in Germany and Austria during the last decade. Europ J Pediatr 2008; 167: 447-453
9. Grabert M, Schweiggert F, Holl RW. A framework for diabetes documentation and quality management in Germany: 10 years of experience with DPV. Comput Meth Prog Biomed 2002; 69: 115-121
10. Holl RW, Grabert M, Sorgo W et al. Contribution of age, gender and insulin administration to weight gain in subjects with IDDM. Diabetologie 1998; 41: 542-547
11. Holcomb JH, Zalani S, Arora VK, et al. Lispro Adolescent study group. Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents. Clin Ther 2002; 24: 629-638
12. Kapellen TM, Heim K, Nietzschmann U et al. Changes in pediatric diabetes care in a 30-yr period at one institution for pediatric diabetology in Germany. Pediatr Diabetes 2002; 3: 70-73
13. Kapellen TM, Galler A, Kiess W. Insulin Treatment. In: Chiarelli F, Dahl-Jorgensen K, Kiess W, eds. Diabetes in Childhood and Adolescence Basel. Karger Verlag; 2005; 122-138
14. Kiess W, Gausche R, Keller A et al. Computer-guided, population-based screening system for growth disorders (CrescNet® ) and on-line generation of normative data for growth and development. Horm Res 2001; 56: 59-66
15. Klinkert C, Bachran R, Heidtmann B et al. For the DPV-initiative age-specific characteristics of the basal insulin-rate for pediatric patients on CSII. Exp Clin Endocrinol Diabetes; eFirst
16. Kromeyer-Hauschild K, Wabitzsch M, Kunze D. Perzentile fürden Bodymass-Index für das Kinder- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 2001; 149: 807-818
17. Murphy NP, Keane S, Ong KK et al. Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimen. Diabetes Care 2003; 26: 799-804
18. Onkamo P, Vaanenen S, Karvonen M et al. Worldwide increase in incidence of type 1 diabetes: the analysis of data on published incidence trends. Diabetologia 1999; 42: 1395-1403
19. Plank J, Siebenhofer A, Berghold A et al. Systematic review and metaanalysis of short acting insulin analogues in pediatric patients with diabetes mellitus. Arch Int Med 2005; 165: 1337-1344
20. Pieber TR, Treichel H-C, Hompesch B et al. Comparison of insulin detemir and insulin glargine in subjects with type 1 diabetes using intensive insulin therapy. Diabetic Medicine 2007; 24: 635-642
21. Ratner RE, Hirsch IB, Neifing JL et al. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. Diabetes Care 2000; 23: 639-643
22. Robertson KJ, Schoenle E, Guvec C et al. Insulin detemir compared with NPH insulin in children and adolescents with type 1 diabetes. Diabet Med 2007; 24: 27-34
23. Rosenbauer J, Icks A, Giani G. Incidence and prevalence of childhood type 1 diabetes mellitus in Germany-model-based national estimates. J Pediatr Endocrinol Metab 2002; 15: 1497-1504 (Pubitemid 36024234)
24. Rutledge KS, Chase P, Klingensmith GJ et al. Effectiveness of postprandial Humalog in toddlers with diabetes. Pediatrics 1997; 100: 968-972
25. Schober E, Schoenle E, Dyk J Van et al. Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocinol Metab 2002; 15: 369-376
26. Siebenhofer A, Plank J, Berghold A et al. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database Syst Rev 2006; (2): CD003287